Published in Skin Pharmacol on January 01, 1997
Treatment of superficial mycoses: review. Part II. An Bras Dermatol (2014) 0.90
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther (2010) 1.83
Effects of two novel cationic staphylococcal proteins (NP-tase and p70)and enterotoxin B on IgE synthesis and interleukin-4 and interferon-gamma production in patients with atopic dermatitis. Br J Dermatol (2000) 1.48
Death due to pulmonary tuberculosis in progressive systemic sclerosis. J Eur Acad Dermatol Venereol (2002) 1.39
HLA in bullous pemphigoid. The probable role of HLA-B7 as a marker for poor responders to immunosuppressive therapy. Int J Dermatol (1991) 1.39
Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol (1990) 1.33
Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the basidiomycete Coprinus sp. in a leukemic patient. J Med Vet Mycol (1997) 1.18
Detection of human soluble Thy-1 in serum by ELISA. Fibroblasts and activated endothelial cells are a possible source of soluble Thy-1 in serum. Cell Tissue Res (1999) 1.18
[Localization of the fibrinolytic activity in the skin]. Arch Klin Exp Dermatol (1966) 1.17
The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1. Arch Dermatol Res (1998) 1.12
Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol (1996) 1.07
Combination of an island advancement flap and a composite graft for reconstruction of the nasolabial defect. Dermatol Surg (1997) 1.06
Antifungal activity of the essential oil of Melaleuca alternifolia (tea tree oil) against pathogenic fungi in vitro. Skin Pharmacol (1996) 1.06
Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg (2000) 1.05
A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. J Invest Dermatol (2000) 1.02
Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA (1991) 0.98
[Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin]. Arch Klin Exp Dermatol (1968) 0.97
[Comparison of skin reactions between animal and man]. Dermatol Monatsschr (1979) 0.97
Case report. Mycotic arteritis due to Aspergillus fumigatus in a diabetic with retrobulbar aspergillosis and mycotic meningitis. Mycoses (2001) 0.96
[The localization of the tissue activator of fibrinolysis in dermatoses]. Arch Klin Exp Dermatol (1969) 0.95
Environmentally induced systemic sclerosis-like disorders. Int J Dermatol (1985) 0.94
[The localization of the tissue activator of fibrinolysis in skin tumors]. Arch Klin Exp Dermatol (1969) 0.93
Aspergillus detection in bronchoscopically acquired material. Significance and interpretation. Mycoses (2001) 0.93
Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheum (1994) 0.90
Anaphylactic shock and contact urticaria after the patch test with professional allergens. Allerg Immunol (Leipz) (1976) 0.87
[On the fibrinolytic activity of the skin]. Arch Klin Exp Dermatol (1966) 0.87
Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis. Arch Dermatol Res (1998) 0.86
In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test. Mycoses (1999) 0.85
Malignant granular cell tumour with generalized metastases and polymyositis. Acta Derm Venereol (2001) 0.84
Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris. Drugs (1995) 0.84
Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Exp Dermatol (2000) 0.84
Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol (2000) 0.84
[Membraneless fibrillar and amorphous granular bodies in lupus erythematosus. Electron microscopic study]. Dermatol Monatsschr (1973) 0.83
The fibroblast-specific MAb AS02: a novel tool for detection and elimination of human fibroblasts. Cell Tissue Res (1997) 0.83
Pulmonary nocardiosis with cutaneous involvement mimicking a metastasizing lung carcinoma in a patient with chronic myelogenous leukaemia. Eur J Dermatol (2000) 0.83
Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. Eur J Dermatol (1998) 0.83
[Clinical findings, differential diagnosis and therapy of vulvar lichen sclerosus et atrophicus ("kaurosis") within the scope of sclerosing genital atrophies]. Zentralbl Gynakol (1969) 0.83
[Electron microscopic studies on the epidermal-dermal junction in lupus erythematosus]. Dermatologica (1972) 0.83
Longitudinal case analysis in atopic dermatitis. Acta Derm Venereol (2001) 0.83
In vitro activity of lithium succinate against Malassezia furfur. Dermatology (1995) 0.83
Systemic sclerosis-related Raynaud's phenomenon: effects of iloprost infusion therapy on serum cytokine, growth factor and soluble adhesion molecule levels. Acta Derm Venereol (2001) 0.82
Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. Br J Dermatol (1990) 0.82
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
Squamous cell carcinoma of the skin--histopathological features and their significance for the clinical outcome. J Eur Acad Dermatol Venereol (1998) 0.82
[Characterization of lymphocytic infiltrate cells in bullous pemphigoid and pemphigus vulgaris]. Dermatol Monatsschr (1990) 0.81
[Electron microscopy studies on the viral pathogenesis of lupus erythematosus]. Dermatol Monatsschr (1972) 0.81
Molecular analysis of different phases in human wound healing. Exp Dermatol (1997) 0.81
8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors. Int J Dermatol (1991) 0.81
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Effect of pepstatin A on Candida albicans infection in the mouse]. Dermatol Monatsschr (1990) 0.81
[Treatment of acne vulgaris with hydrogen peroxide emulsion (L/W)]. Dermatol Monatsschr (1987) 0.80
Acid lysosomal hydrolases in systemic sclerosis and other connective tissue diseases. Br J Dermatol (1982) 0.80
Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses (1997) 0.80
The equatorial fibronectin band (EFB) on human spermatozoa--a diagnostic help for male fertility? Andrologia (1987) 0.79
[Infrared photodocumentation of the superficial venous system of the leg]. Asthet Med (Berl) (1967) 0.79
Chemokine release from activated human dermal microvascular endothelial cells--implications for the pathophysiology of scleroderma? Arch Dermatol Res (2000) 0.79
Differentiation of Candida strains by lectin-mediated agglutination kinetics. Mycoses (2000) 0.79
[Detection of fibrin deposits in lichen ruber planus by immunofluorescence]. Dermatol Monatsschr (1970) 0.79
[Detection of a plasminogen-like substance in healthy human skin]. Dermatol Monatsschr (1969) 0.79
Transforming growth factor-beta controls cell-matrix interaction of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol (1996) 0.79
In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis. J Rheumatol (1997) 0.79
[Dyskeratotic senile keratoma and warty dyskeratoma]. Hautarzt (1967) 0.79
[Metaplastic reticulosis with eosinophilic leukemoid and final lymphoid cell push stimulating the picture of generalized erythroderma]. Dermatol Wochenschr (1967) 0.78
[The Langerhans cell--its macrophages-analogous function in the triggering of the allergic contact eczema (author's transl)]. Allerg Immunol (Leipz) (1979) 0.78
[Quartz-induced scleroderma. Scleroderma-like syndrome or true progressive scleroderma?]. Dermatol Monatsschr (1986) 0.78
Differences in the intracellular killing of proteinase-positive and proteinase-negative Candida albicans strains by granulocytes. Mykosen (1986) 0.78
[Rare and newly described histological variants of cutaneous squamous epithelial carcinoma. Classification by histopathology, cytomorphology and malignant potential]. Hautarzt (2001) 0.78
Silica-induced lupus erythematosus. Acta Derm Venereol (1998) 0.78
Allergic and irritant potential of benzoyl peroxide. Contact Dermatitis (1985) 0.78
Detection of basement membrane zone antigens and C3 fragments in the blister fluid of bullous pemphigoid. Br J Dermatol (1980) 0.78
Effects of monochromatic ultraviolet irradiation (300-400 nm) on viability of human white blood cells. Photodermatol Photoimmunol Photomed (1990) 0.78
The small proteoglycan fibromodulin is expressed in mitotic, but not in postmitotic fibroblasts. Mol Cell Biol Res Commun (1999) 0.78
[Sclerosing genital atrophy as the cause of phimosis: kraurosis penis--balanitis xerotica obliterans--lichen sclerosus et atrophicus]. Dtsch Gesundheitsw (1968) 0.77
Pathogenesis of progressive systemic sclerosis. Int J Dermatol (1986) 0.77
[Histological and ultrastructural findings in histiocytosis gigantocellularis (multicentric reticulohistiocytosis)]. Dermatologica (1973) 0.77
[Fibrinolytic activity of epithelial cells]. Dermatologica (1971) 0.77
Steady-state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol (1991) 0.77
Pathogenetic studies in bullous pemphigoid--review of the literature and our own results. J Dermatol (1984) 0.77
Ultrastructure of macrophage-lymphocyte interaction in purpura pigmentosa progressiva. Dermatologica (1976) 0.77
[Sports-induced infections--an overview]. Wien Med Wochenschr (2002) 0.77
Cutaneous breast angiosarcoma after conserving treatment of breast cancer. Eur J Dermatol (2001) 0.77
Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris. Eur J Clin Microbiol Infect Dis (1992) 0.77
[Stevens-Johnson syndrome with transition to toxic epidermal necrolysis after carbamazepine administration, heroin and alcohol abuse]. Hautarzt (1999) 0.77
The role of bullous pemphigoid antibodies in dermal-epidermal separation. J Invest Dermatol (1989) 0.77
In vitro analysis of adhesion molecule expression and gel contraction of human granulation fibroblasts. Wound Repair Regen (2006) 0.77
Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability. Dermatology (1998) 0.76
[Effect of synthetic antifibrinolytics on allergic reactions]. Dermatol Wochenschr (1967) 0.76
Violin chin rest eczema due to east-indian rosewood (Dalbergia latifolia ROXB). Contact Dermatitis (1982) 0.76
[Unusual nuclear inclusions in lymphocytes and basal cells of the skin in lupus erythematosus]. Dermatologica (1973) 0.76
[Invasive mold infections in the university clinics of Leipzig in the period from 1992-1994]. Mycoses (1996) 0.76
[On the effect of the antifibrinolytic agent p-aminomethylbenzoic acid (PAMBA) on transplantation immunology in mice]. Allerg Asthma (Leipz) (1967) 0.76
In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection. Mycoses (1999) 0.75
Juvenile papular-purpuric gloves and socks syndrome. J Eur Acad Dermatol Venereol (2001) 0.75
Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm Venereol (1996) 0.75